Scalable Manufacturing Platform for RNA-LNP Vaccine Development

Time: 3:15 pm
day: Day One Morning


  • COVID-19 mRNA vaccines, while an extraordinary accomplishment, have revealed that rapid development and scale-up, as well as access to innovative technologies, are needed to keep up with emerging variants and to usher in a new wave of genomic medicines
  • Challenges associated with addressing a global pandemic include the need for a scalable, quick and localized manufacturing platform as well as the need for a higher potency vaccine
  • In this presentation, we will share insights into a cutting-edge technology to enable scalable manufacturing for RNA-LNPs and the use of this technology for the development of a high potency saRNA-LNP COVID vaccine